VR Logo

Windtree Therapeutics Inc. (WINT) download report


Healthcare | Biotechnology & Pharma Research

Windtree Therapeutics Inc. (WINT) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases.

IPO Date: 08-Aug-1995

Pres, CEO & Director: Mr. Craig E. Fraser

Sr. VP, CFO, Treasurer & Corp. Sec.: Mr. John P. Hamill CPA

Listing: NASDAQ: WINT

Country: United States

Headquarters: Warrington, PA

Website: https://windtreetx.com

Key Facts

Market cap: $12.06 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-66.80 Mln

Cash: $15.54 Mln

Total Debt: $2.42 Mln

Insider's Holding: 30.42%

Liquidity: Low

52 Week range: $0.35 - 2.40

Shares outstanding: 29,406,200

10 Years Aggregate:

  • CFO: $-292.06 Mln
  • EBITDA: $-338.29 Mln
  • Net Profit: $-387.91 Mln

Stock Performance

Time Period Windtree Therapeutics (WINT) S&P BSE Sensex* S&P Small-Cap 600*
YTD-74.530.40-11.58
1 month-4.657.958.86
3 months-43.846.66-2.19
1 Year-78.977.75-6.23
3 Years-67.7616.819.73
5 Years-49.5912.637.72
10 Years-57.4012.7610.81
As on 05-Aug-2022 *As on 08-Aug-2022
Year Windtree Therapeutics (WINT) S&P Small-Cap 600 S&P BSE Sensex
2021-68.6225.2721.99
2020-59.769.5715.75
2019-15.0020.8614.38
201818.93-9.705.87
2017-83.2011.7327.91
2016-58.2624.741.95
2015-81.56-3.36-5.03